Search results
Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study
Zacks via Yahoo Finance· 2 hours agoApellis (APLS) rises 3.3% as the treatment of GA patients with Syfovre demonstrates a visual...
Insulin-treated type 2 diabetes patients unwilling to participate in intensive lifestyle...
Medical Xpress· 3 hours agoFor adults with advanced, insulin-treated type 2 diabetes (T2D), willingness to participate in an...
FDA advisory panel recommends new Alzheimer's drug after scrutiny
UPI· 1 hour agoEli Lilly's donanemab did slow declines in thinking skills in patients with early-stage Alzheimer's:...
DM Clinical Research Announces Grand Opening of New Clinical Site in Phoenix
KTBS Shreveport· 4 days agoThe Phoenix site is strategically located to enhance DM ClinicalResearch's ability to serve a...
Scientists probe a space mystery: Why do people age faster during space travel?
USA TODAY via Yahoo News· 19 minutes agoThe lessons learned from space travelers could help folks on Earth, too, the researchers said....
Lab-grown 'mini-guts' to help Crohn's patients
BBC via Yahoo News· 2 hours agoThese switches are attached to DNA that turn genes on and off - or turn their activity up or down - leaving the DNA itself intact, but changing the way a cell functions. These changes in Crohn's ...
Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
Zacks via Yahoo Finance· 1 hour agoStructure Therapeutics (GPCR) stock sees an upside on positive top-line data from a phase IIa...
Researchers find significant racial disparities in who has access to CAR-T therapy
Medical Xpress· 4 hours agoPenn Medicine's patients of color are far less likely than white patients to receive a novel gene...
Charles River (CRL) Partners to Reduce Animal Research Usage
Zacks via Yahoo Finance· 3 hours agoThe development is likely to boost the company’s Discovery and Safety Assessment (“DSA...company...
MDs' One-Word Summary of Long COVID Progress: 'Frustration'
Medscape· 10 hours agoFor long COVID doctors and patients, there has been little to no progress addressing the challenges,...
